Cornerstone Capital Management Holdings’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,524	Closed	-$324K	–	1516
2016 Q1	$324K	Sell	2,524 -2,339	-48%	-$276K	﹤0.01%	1124
2015 Q4	$727K	Sell	4,863 -3,473	-42%	-$588K	0.01%	964
2015 Q3	$1.38M	Buy	+8,336	New	+$1.83M	0.01%	808
2014 Q4	–	Sell	-300	Closed	-$71K	–	1335
2014 Q3	$71K	Sell	300 -100	-25%	-$25.5K	﹤0.01%	1199
2014 Q2	$93K	Sell	400 -1,050	-72%	-$277K	﹤0.01%	1187
2014 Q1	$478K	Buy	+1,450	New	+$489K	0.01%	990

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cornerstone Capital Management Holdings's ICPT Position: Q2 2016 in Review

Cornerstone Capital Management Holdings sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2016, closing a stake of 2,524 shares — an estimated $324K sold.

Cornerstone Capital Management Holdings first reported a position in ICPT in Q1 2014 and held it in 6 quarters. The position peaked at $1.38M in Q3 2015. 167 funds tracked by Wall St. Rank hold ICPT as of Q2 2016.

Cornerstone Capital Management Holdings reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 2,524 Intercept Pharmaceuticals, Inc. shares in Q2 2016, an estimated $324K.
Cornerstone Capital Management Holdings first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 6 quarters.
Cornerstone Capital Management Holdings's Intercept Pharmaceuticals, Inc. position peaked at $1.38M in Q3 2015.
167 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.